Engensis

VM202 · Helixmith Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Engensis, covering 2023-02-22 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis [Phase 2]